Photo from Paolo Tarantino/Twitter
Aug 6, 2023, 17:11
Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year – Paolo Tarantino
With ESMO23 and SABCS23 approaching, we may soon see the results from several potentially practice-changing trials in breast oncology. Here’s a personal, non-exhaustive selection of highly awaited phase 3 trials that may shape practice within the next year.
Source: Paolo Tarantino / Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Sep 8, 2025, 02:50
Sep 8, 2025, 02:00
Sep 7, 2025, 23:56
Sep 7, 2025, 23:47
Sep 7, 2025, 16:47
Sep 7, 2025, 16:30
Sep 7, 2025, 16:25